WiseWear launches Vigilant device
SAN ANTONIO ‑ WiseWear, a provider of connected health and safety devices and services, and Ingenu Inc., have launched the Vigilant Safety and Security Device, a tracking and communication solution. Powered by Ingenu’s Random Phase Multiple Access network technology, Vigilant is a standalone safety device that is directly connected to the Internet and emergency response dispatch centers. “RPMA technology is ideally suited for a solution such as Vigilant, as it provides easy connectivity and global coverage,” said Joshua Builta, vice president, product management at Ingenu, in a statement. The modular design of the Vigilant device provides a wearable form factor that can be attached to a keychain, clip or watch. Vigilant alerts are communicated directly from the device when an individual leaves the predesignated “safe” geo-fenced area, providing GPS coordinates and messaging to a list of selected contacts.
dacadoo releases upgraded version of digital health engagement platform
ZURICH – Digital health technology company dacadoo has launched a new version of its digital health engagement platform. “Platform release 3.5.0 not only contains multiple improvements on existing features and usability based on user feedback but also introduces key new features which will help increase our user engagement,” said Peter Ohnemus, founder and CEO of dacadoo, in a statement. Upgrades to the platform include a redesign of the signup process, the addition of lifestyle-based articles, and connection to the Google Fit and Samsung Health app. The platform helps users actively manage their health with motivational techniques from online games, collaborative features from social networks, personalized feedback and the patented dacadoo Health Score to better understand and improve their health. The technology is provided to health and life insurance companies, health & wellness service organizations, and large- and mid-sized employers for health promotion in the workplace.
Abbott, Bigfoot Biomedical develop calibration-free insulin delivery system
ABBOTT PARK, Ill. and MILPITAS, Calif. – Abbott Laboratories and Bigfoot Biomedical will collaborate to develop and commercialize diabetes management systems, integrating Abbott’s FreeStyle Libre glucose sensing technology with Bigfoot’s insulin delivery solutions. “Together with Bigfoot, we are challenging conventional methods of diabetes management by bringing together our expertise in superior glucose monitoring technology with a best-in-class insulin delivery system that is designed with the patient in mind,” said Jared Watkin, senior vice president of Diabetes Care at Abbott, in a statement. As part of the agreement, Abbott will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology, which Bigfoot will use to develop personalized, user-friendly systems intended to optimize insulin delivery without the need for fingerstick calibration of a glucose sensor. “A no-calibration glucose sensor is the final piece of the puzzle needed to enable consumer-friendly and accessible integrated insulin delivery systems,” said Jeffrey Brewer, president and CEO of Bigfoot Biomedical, in a statement.
iBeat raises $3M to advance cardiac smartwatch
SAN FRANCISCO – Wearable technology company iBeat, which makes a smartwatch that continually monitors heart activity, has raised an additional $3 million in funding, bringing its total seed stage funding to $4.5 million. “The funding from new and existing investors not only validates the important work our team has done in demonstrating the watch’s ability to recognize life-threatening heart emergencies, but is also an affirmation of our technology and will help sustain our greater vision to reduce preventable deaths from these emergencies,” said Ryan Howard, founder and CEO of iBeat, in a statement. The company plans to use the additional funds to begin clinical testing, refine its sales and marketing strategies, continue hiring, and further scale its tooling and manufacturing operations. iBeat has also added Dr. Mintu Turakhia of Stanford University and Apple product veterans Roby DeManche and Drew Atkinson to its executive team.
Novo Nordisk, Glooko collaboration brings new diabetes management app
PRINCETON, N.J. and MOUNTAIN VIEW, Calif. – A collaboration between health care company Novo Nordisk and diabetes care management company Glooko has created the Cornerstones4Care Powered by Glooko app to help people more effectively manage their diabetes. “Our companies share a common vision of empowering patients with ever improving digital health solutions and we are excited about our combined capabilities and what that can do for improving diabetes treatment,” said David Moore, senior vice president of marketing at Novo Nordisk, in a statement. The C4C mobile app merges Novo Nordisk’s knowledge of diabetes and personalized patient support with Glooko’s digital platform and data analytics expertise. This is the first jointly developed product from the two companies since announcing their collaboration in January 2017. Novo Nordisk is also working with Glooko to enhance its digital health platform.
Finalists announced in Alexa Diabetes Challenge
NEW YORK – Five finalists have been announced in the Alexa Diabetes Challenge, a multi-stage prize competition sponsored by Merck & Co. for innovators to develop Alexa voice-enabled solutions for diabetes patients.
“We are extremely impressed with the novel thinking brought forth in the finalist submissions,” said Kimberly Park, vice president of customer strategy and innovation, global human health, Merck, in a statement. “These five concepts help us envision how voice technology can help improve health and quality of life for patients with chronic diseases such as Type 2 diabetes.”
The competition received 96 submissions from across the health care landscape, including research institutions, software companies, startups and health care providers for ideas for voice-enabled solutions to improve the lives of those with Type 2 diabetes.
Each finalist received $25,000 and 10,000 Amazon World Services promotional credits to advance to the Virtual Accelerator, where they will receive expert mentorship as they continue to develop their proposals.
The five finalists are:
DiaBetty, University of Illinois: A virtual diabetes educator and at-home coach that is sensitive and responsive to the patient’s mood, enhancing patient skills for self-management.
My GluCoach, HCL America, Inc.: A holistic management solution that blends the roles of voice-based diabetes teacher, lifestyle coach and personal assistant to serve the individual and specific needs of the patient.
PIA: Personal intelligent agents for Type 2 diabetes, Ejenta: A connected care intelligent agent that uses NASA-licensed AI technology integrated with IoT device data to encourage healthy habits, detect at-risk behaviors and abnormalities, and alert care teams.
Sugarpod, Wellpepper: A multimodal solution, including a smart foot scanner, that provides specialized voice, mobile, video and web interactions based on the task and patient preferences to support patient adherence to comprehensive care plans.
T2D2: Taming Type 2 diabetes, together, Elliot Mitchell, Biomedical Informatics PhD Student at Columbia University, and team: A virtual nutrition assistant that uses machine learning to provide in-the-moment personalized education and recommendations, as well as meal planning, and food and glucose logging.
The winner of the Alexa Diabetes Challenge will receive $125,000.